Latest Insider Transactions at Syneos Health, Inc. (SYNH)
This section provides a real-time view of insider transactions for Syneos Health, Inc. (SYNH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Syneos Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Syneos Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 22
2018
|
Christopher L Gaenzle CAO, GC & Sec |
SELL
Open market or private sale
|
Direct |
1,470
-2.67%
|
$60,270
$41.0 P/Share
|
|
Jan 19
2018
|
Christopher L Gaenzle CAO, GC & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
793
-1.42%
|
$31,720
$40.9 P/Share
|
|
Jan 19
2018
|
Alistair Macdonald Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,293
-1.3%
|
$51,720
$40.9 P/Share
|
|
Sep 18
2017
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,348
-2.31%
|
$126,792
$54.6 P/Share
|
|
Sep 18
2017
|
Gregory S Rush Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,703
-10.99%
|
$523,962
$54.48 P/Share
|
|
Sep 18
2017
|
Christopher L Gaenzle CAO, GC & Sec |
SELL
Open market or private sale
|
Direct |
4,682
-7.73%
|
$252,828
$54.55 P/Share
|
|
Sep 15
2017
|
Christopher L Gaenzle CAO, GC & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
4,245
-6.55%
|
$229,230
$54.85 P/Share
|
|
Sep 01
2017
|
Christopher L Gaenzle CAO, GC & Sec |
SELL
Open market or private sale
|
Direct |
42,601
-9.11%
|
$2,470,858
$58.77 P/Share
|
|
Sep 01
2017
|
Christopher L Gaenzle CAO, GC & Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
42,601
+14.24%
|
$511,212
$12.23 P/Share
|
|
Sep 01
2017
|
Gregory S Rush Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
88,739
-12.43%
|
$5,146,862
$58.81 P/Share
|
|
Sep 01
2017
|
Gregory S Rush Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
98,739
+18.43%
|
$2,172,258
$22.08 P/Share
|
|
Aug 30
2017
|
Gregory S Rush Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
41,420
-63.88%
|
$2,402,360
$58.25 P/Share
|
|
Aug 30
2017
|
Gregory S Rush Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,917
+30.94%
|
$94,672
$16.06 P/Share
|
|
Aug 30
2017
|
Gregory S Rush Chief Financial Officer |
SELL
Exercise of conversion of derivative security
|
Direct |
35,503
-45.34%
|
$355,030
$10.06 P/Share
|
|
Aug 17
2017
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,828
-7.98%
|
$485,540
$55.65 P/Share
|
|
Aug 17
2017
|
Alistair Macdonald Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,828
+7.39%
|
$88,280
$10.57 P/Share
|
|
Aug 01
2017
|
Alistair Macdonald Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
32,614
+13.97%
|
-
|
|
Aug 01
2017
|
Michael Adam Bell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
16,822
-13.34%
|
$925,210
$55.85 P/Share
|
|
Aug 01
2017
|
Alistair Macdonald Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,193
-3.96%
|
$230,615
$55.85 P/Share
|
|
Aug 01
2017
|
Thomas H. Lee Advisors, LLC |
BUY
Grant, award, or other acquisition
|
Direct |
8,712
+50.0%
|
-
|
|
Aug 01
2017
|
Gregory S Rush Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,527
+14.05%
|
-
|
|
Aug 01
2017
|
Christopher L Gaenzle CAO, GC & Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
18,330
+13.26%
|
-
|
|
Aug 01
2017
|
Michael Gibertini |
BUY
Exercise of conversion of derivative security
|
Direct |
21,567
+12.93%
|
-
|
|
Jul 03
2017
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,088
-1.46%
|
$63,104
$58.55 P/Share
|
|
Jul 03
2017
|
Christopher L Gaenzle CAO, GC & Sec |
SELL
Open market or private sale
|
Direct |
956
-2.01%
|
$55,448
$58.55 P/Share
|
|
Jun 30
2017
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,467
-11.28%
|
$549,086
$58.36 P/Share
|
|
Jun 30
2017
|
Alistair Macdonald Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,467
+10.14%
|
$151,472
$16.06 P/Share
|
|
Jun 30
2017
|
Christopher L Gaenzle CAO, GC & Sec |
SELL
Open market or private sale
|
Direct |
5,917
-11.29%
|
$343,186
$58.28 P/Share
|
|
Jun 30
2017
|
Christopher L Gaenzle CAO, GC & Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
5,917
+10.14%
|
$94,672
$16.06 P/Share
|
|
Jun 30
2017
|
Christopher L Gaenzle CAO, GC & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
867
-1.79%
|
$50,286
$58.5 P/Share
|
|
Jun 30
2017
|
Michael Gibertini |
SELL
Payment of exercise price or tax liability
|
Direct |
576
-1.0%
|
$33,408
$58.5 P/Share
|
|
Jun 30
2017
|
Gregory S Rush Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
967
-1.74%
|
$56,086
$58.5 P/Share
|
|
May 23
2017
|
David F Burgstahler Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,693
+6.5%
|
-
|
|
May 23
2017
|
Robert W Breckon Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,693
+30.78%
|
-
|
|
May 23
2017
|
Linda S Harty Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,693
+45.64%
|
-
|
|
May 23
2017
|
Richard N Kender Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,693
+27.37%
|
-
|
|
May 23
2017
|
William E Klitgaard Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,693
+45.64%
|
-
|
|
May 23
2017
|
Kenneth F Meyers Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,693
+40.75%
|
-
|
|
May 23
2017
|
Matthew E. Monaghan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,693
+40.75%
|
-
|
|
May 23
2017
|
David Y Norton Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,693
+27.82%
|
-
|
|
May 23
2017
|
Eric Paques Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,693
+45.42%
|
-
|
|
May 01
2017
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,467
-11.28%
|
$426,015
$45.0 P/Share
|
|
May 01
2017
|
Alistair Macdonald Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,467
+10.14%
|
$151,472
$16.06 P/Share
|
|
Apr 03
2017
|
Christopher L Gaenzle CAO, GC & Sec |
SELL
Open market or private sale
|
Direct |
4,733
-8.92%
|
$212,985
$45.7 P/Share
|
|
Apr 03
2017
|
Christopher L Gaenzle CAO, GC & Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
4,733
+8.19%
|
$47,330
$10.57 P/Share
|
|
Mar 03
2017
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,828
-10.6%
|
$397,260
$45.0 P/Share
|
|
Mar 03
2017
|
Alistair Macdonald Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,828
+9.58%
|
$88,280
$10.57 P/Share
|
|
Mar 01
2017
|
Linda S Harty Director |
BUY
Grant, award, or other acquisition
|
Direct |
514
+50.0%
|
-
|
|
Mar 01
2017
|
William E Klitgaard Director |
BUY
Grant, award, or other acquisition
|
Direct |
514
+50.0%
|
-
|
|
Feb 08
2017
|
Eric Paques Director |
BUY
Grant, award, or other acquisition
|
Direct |
543
+50.0%
|
-
|